| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |